BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23373820)

  • 21. Non-dopaminergic treatments in development for Parkinson's disease.
    Fox SH; Brotchie JM; Lang AE
    Lancet Neurol; 2008 Oct; 7(10):927-38. PubMed ID: 18848312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomic dysfunction in Parkinson's disease.
    Micieli G; Tosi P; Marcheselli S; Cavallini A
    Neurol Sci; 2003 May; 24 Suppl 1():S32-4. PubMed ID: 12774210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue in Parkinson's disease.
    Friedman JH; Abrantes A; Sweet LH
    Expert Opin Pharmacother; 2011 Sep; 12(13):1999-2007. PubMed ID: 21635199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autonomic dysfunction in Parkinson's disease.
    Dewey RB
    Neurol Clin; 2004 Oct; 22(3 Suppl):S127-39. PubMed ID: 15501361
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of Parkinson's disease.
    Davie CA
    Br Med Bull; 2008; 86():109-27. PubMed ID: 18398010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dry mouth: an overlooked autonomic symptom of Parkinson's disease.
    Cersosimo MG; Raina GB; Calandra CR; Pellene A; Gutiérrez C; Micheli FE; Benarroch EE
    J Parkinsons Dis; 2011; 1(2):169-73. PubMed ID: 23939300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut dysfunction in Parkinson's disease.
    Mukherjee A; Biswas A; Das SK
    World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autonomic Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Neurotherapeutics; 2020 Oct; 17(4):1464-1479. PubMed ID: 32789741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLV-308. Solvay.
    Wolf WA
    Curr Opin Investig Drugs; 2003 Jul; 4(7):878-82. PubMed ID: 14619412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigational drugs for autonomic dysfunction in Parkinson's disease.
    Perez-Lloret S
    Expert Opin Investig Drugs; 2016; 25(3):259-62. PubMed ID: 26757448
    [No Abstract]   [Full Text] [Related]  

  • 31. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease.
    Sakakibara R; Shinotoh H; Uchiyama T; Sakuma M; Kashiwado M; Yoshiyama M; Hattori T
    Auton Neurosci; 2001 Sep; 92(1-2):76-85. PubMed ID: 11570707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Parkinson's disease a review of current and new therapies.
    Mendis T; Suchowersky O; Lang A; Gauthier S
    Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing.
    Wüllner U; Schmitz-Hübsch T; Antony G; Fimmers R; Spottke A; Oertel WH; Deuschl G; Klockgether T; Eggert K;
    Eur J Neurol; 2007 Dec; 14(12):1405-8. PubMed ID: 17941852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
    Montastruc JL; Senard JM; Rascol O; Rascol A
    Adv Neurol; 1996; 69():377-81. PubMed ID: 8615154
    [No Abstract]   [Full Text] [Related]  

  • 35. Autonomic disorders in idiopathic parkinsonism.
    Martignoni E; Micieli G; Cavallini A; Pacchetti C; Magri M; Nappi G
    J Neural Transm Suppl; 1986; 22():149-61. PubMed ID: 3465869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ropinirole in the symptomatic treatment of Parkinson's disease.
    Brooks DJ; Torjanski N; Burn DJ
    J Neural Transm Suppl; 1995; 45():231-8. PubMed ID: 8748630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
    Diaz NL; Waters CH
    Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Autonomic Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Semin Neurol; 2017 Apr; 37(2):176-185. PubMed ID: 28511258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of gastrointestinal symptoms in Parkinson's disease.
    Salat-Foix D; Suchowersky O
    Expert Rev Neurother; 2012 Feb; 12(2):239-48. PubMed ID: 22288679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.